World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-OPC-15006122
Date of registration: 2015-03-16
Prospective Registration: Yes
Primary sponsor: Lianyungang Oriental Hospital
Public title: The Effect of Ultrasound-guided Ropivacaine Combined with Dexmedetomidine in Fascia Iliaca Compartment Block for Postoperative Analgesia After Lower Limb Fracture Operation
Scientific title: The Effect of Ultrasound-guided Ropivacaine Combined with Dexmedetomidine in Fascia Iliaca Compartment Block for Postoperative Analgesia After Lower Limb Fracture Operation
Date of first enrolment: 2015-04-01
Target sample size: Group R:25;Group RD :25;
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10611
Study type:  Observational study
Study design:  Cross-sectional  
Phase:  I (Phase I study)
Countries of recruitment
China
Contacts
Name: Zhang Qian   
Address:  57 Zhonghua West Road, Lianyun District, Lianyungang, Jiangsu
Telephone: +86 15262005637
Email: 15262005637@163.com
Affiliation:  Lianyungang Oriental Hospital
Name: Cheng Fang   
Address:  57 Zhonghua West Road, Lianyun District, Lianyungang, Jiangsu
Telephone: +86 13851260712
Email: chengfang-1991@163.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients with Lower Limb Fracture, ASA I-II grade,BMI 18~24 kg/m2.
Exclusion criteria: Patients can not cooperate and exchange;Severe liver, kidney and blood system dysfunction; Formulation ingredients used in this study for patients with a history of allergy; Block failure patients.

Age minimum: 18
Age maximum: 60
Gender: Both
Health Condition(s) or Problem(s) studied
Lower Limb Fracture
Intervention(s)
Group R:Use ropivacaine;Group RD :use dexmedetomidine and ropivacaine;
Primary Outcome(s)
VAS;OAA/S;CRP;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Municipal Health Bureau, Commitment unit
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history